Two recent studies conducted by scientists at the University Health Network and the University of Toronto provide new ...

— Study Published in Psychopharmacology and Presented at the 12 th Clinical Trials on Alzheimer’s Disease (CTAD) Shows Favorable Safety and Tolerability Profile of Regular Low Dose LSD —Scientific ...

Lysergic acid diethylamide, or LSD, is a potent hallucinogen that alters the perception of reality. Researchers at Baylor College of Medicine have discovered changes in the brain, triggered by the ...

Texas passed a landmark law in June 2025, supported by former Gov. Rick Perry, that allocates US$50 million to support research on ibogaine, one of the most powerful psychedelics, for treating opioid ...

In the ‘50s through the ‘70s, psychedelic drugs were studied for their potential to help people stop problematic drinking. At the time, the research primarily focused on the effects of lysergic acid ...

Albert Hofmann, the Swiss chemist who discovered LSD and thereby gave the psychedelic generation the pharmaceutical vehicle to turn on, tune in and drop out, has died. He was 102. Hofmann died Tuesday ...

A little bit of hallucinogen can go a long way in alleviating physical pain. New research has found that a microdose of lysergic acid diethylamide (LSD) significantly increases human pain tolerance ...

IN view of the blocking effect often exerted by the close chemical analogue of a pharmacologically specific agent, we tried to determine whether the psychological symptoms induced by D-lysergic acid ...

Swiss scientist Albert Hofmann was born January 11, 1906 and died April 29, 2008. In an exclusive interview published in the July, 1976 edition of High Times, Hofmann looked back at his illustrious ...